| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | SDIP has unique patented platform that will revolutionize the world of fixation implants. SDIP`s compounds totally adsorb to the body when the host cells repair the damaged tissue avoiding unnecessary removal surgical interventions. In last two decades, there have been numerous attempts to develop bioresorbable fixation implants, but these devices have fallen short in providing the optimal degradation and also they degrade to acidic by-products causing local inflammation and delayed tissue regeneration. SDIP leaves no acidic/basic by-products behind. The properties of SDIP can be tuned to address different clinical needs in fixing a range of damaged soft and interface tissues. At SDIP Innovations, we are committed to stick to the customer-driven strategies tightly in the mission of revolutionizing the resorbable implants and provide a universally safer option for the patients. |
| Category: | Health & biotech |
| URL: | https://zcs1.campaign-view.com/ua/SharedView?od=2d5a885a69b60a972d5b4fd0264f501201185630859ca1fd0&cno=11a2b0b2052bcdd&cd=1141b74af01b9680&m=6 |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2018 |
| Address: | 145/4 Cornwallis St, Eveleigh, Sydney, NSW 2015, AU |
| State: | New South Wales |
| Overseas Operations: | Yes |
| Twitter: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/sdip-innovations |
| Founders: | |
| Awards won: | |
